Full-year 2024 revenue guidance was increased, reflecting high growth expectations. Inari Medical reported strong revenue growth in its third-quarter 2024 earnings but faced a net loss due to ...

PORTAGE, Mich., March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.

Inari Medical, Inc. has a 52 week low of $36.73 and a 52 week high of $79.99. The company has a market capitalization of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. Inari Medical Profile ...